This looks like another underfunded quasi-Canadian biotech. It has been listed on the TSX Venture exchange for years, and this offering came as a 48% discount to its last close TSXV close.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.